At Sensei Biotherapeutics, we develop conditionally active antibodies that are designed to function selectively in the tumor microenvironment to tilt the power of the immune system against cancer. The Sensei team brings together leaders with deep expertise in our core disciplines, along with a highly accomplished team of life science business leaders.

Leadership Team


John K. Celebi, MBA

President & Chief Executive Officer

Chris Gerry 1 17 23

Christopher Gerry, J.D.

Senior Vice President, General Counsel

EdwardVanderHorst web

Edward van der Horst, Ph.D.

Chief Scientific Officer

StephanieKrebs web

Stephanie Krebs, M.S., MBA

Chief Business Officer

Ron Weitzman

Ron Weitzman, M.D., F.A.C.P.

Chief Medical Officer (part-time)

Board of Directors

William Ringo, MBA

Board Chair

John K. Celebi, MBA

Bob Holmen, J.D.

Kristian Humer, MBA

James Peyer, Ph.D.

Tom Ricks, MBA

Deneen Vojta, M.D.

Immuno-Oncology Advisory Board

Alain Algazi, M.D.

Maura Gillison, M.D., Ph.D.

Sara Pai, M.D., Ph.D.

Robert Schreiber, Ph.D.

Daniel H. Sterman, M.D.

Richard Ulevitch, Ph.D.

HQ: 1405 Research Blvd, Suite 125,
Rockville, MD 20850

MA: 22 Boston Wharf Rd, 7th Floor,
Boston, MA 02210